Integrated facilities management for a multinational pharmaceuticals company

Faced with the global acquisition of a pharmaceutical company, the real estate team at client side needed help to meet their value capture targets fast. The Company engaged JLL to help rationalise consolidation efforts for their Ex-U.S. portfolio and to realise their goals in a quick time frame

JLL assisted the team in developing a portfolio consolidation and integration plan involving 55 different markets internationally and over 160 properties, 12M sq. ft. and $330M in annual occupancy costs

Established integration management protocols to ensure discreet management of confidential strategic initiatives

Baselined, validated and confirmed the current supply and demand of the combined portfolio resulting in a master database for the combined organisation

Filtered over 600 assets in more than 100 markets to drive value capture towards the $75M ex-U.S. synergy target

Vetted market conditions at the asset level with the JLL international brokerage network to confirm and substantiate strategies

Integrated workplace strategies to accommodate progressive work styles and drive broader efficiencies in the portfolio

Evaluated over 100 regional scenarios to ensure optimal line-of-business buy-in (what works, what doesn’t work)

Presented findings and recommendations to regional business leads and executive committee for execution

Created an integrated execution framework to address complex nuances such as works’ councils, logistics, move management, and attrition associated with post-merger integration

Results led to consolidation plans which identified between $54M and $83M in annual cost savings and will meet their value capture goal between 34% and 52% for the Ex-US portfolio

All of our recommendations were accepted by the Company’s executive committee without exception and have been implemented